Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06937827 · ClinicalTrials.gov registry record · NA

Transitions of Care Clinic (TOCC)

A NA study of Heart Failure With Preserved Ejection Fraction, sponsored by Hackensack Meridian Health.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06937827: Recruiting NA study of Heart Failure With Preserved Ejection Fraction, sponsored by Hackensack Meridian Health.

NCT06937827 is a NA study of Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 150 participants, below the 2,285-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06937827, a NA study of Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Hackensack Meridian Health.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The transition period from hospital to home is a time of heightened risk for patients to experience adverse events, medication errors, and readmission to the hospital. Patients at the highest risk include older adults and patients with low health literacy, socioeconomic disadvantages, and/or multiple comorbidities. This project proposes to expand the existing Transitions of Care Clinic (TOCC) which was recently introduced in our institution in 2024, to bridge the gap in care between hospital discharge to home and connect discharged patients to their outpatient providers with a focus on patients with heart failure (HF). The existing TOCC, a multidisciplinary team composed of a pharmacist and a nurse practitioner, seeks to improve the services that are currently being provided to patients and enhance the transitions of care process by providing patients with education, tools, and resources to help manage their chronic disease. With this study, we propose to expand TOCC by offering extensive education to patients via iPad videos and providing them with HF tool kits prior to their discharge. We will also assist with scheduling follow appointments with their outpatient providers and follow up with patients after the appointment takes place to re-evaluate their needs and reinforce self management of heart failure. By targeting patients being treated for acute exacerbation of heart failure with preserved ejection fraction (HFpEF), this study aims to facilitate the transition of care, reduce hospital readmissions and improve patients' quality of life and satisfaction. Patients with HFpEF represent a majority of the HF patients that are readmitted at OUMC. HFpEF patients have fewer guideline recommended treatments and represent a vulnerable patient population. The HF tool kits will provide these patients with the essential tools, resources, and log sheets for self-management such as monitoring daily weights, monitoring blood pressure and heart rate. Patients provided with

Primary Outcome

This measures the percentage of patients initially hospitalized for HF who are readmitted to the hospital for any reason within 30 days of discharge. This is a standard metric for evaluating HF care and aligns directly with the objective of reducing readmissions.

Interventions

  • BEHAVIORAL HF Kit and Follow-ups

Study Locations (1)

New Jersey

  • Ocean University Medical Center - Brick

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-06-26
Est. Completion 2027-04-15
Phase NA
Hackensack Meridian Health

90 total trials

What NCT06937827 shows while recruiting

NCT06937827 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,285-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which HF Kit and Follow-ups is the first listed.

NCT06937827 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06937827 about?

NCT06937827 is a clinical study titled "Transitions of Care Clinic (TOCC)". The transition period from hospital to home is a time of heightened risk for patients to experience adverse events, medication errors, and readmission to the hospital. Patients at the highest risk include older adults and patients with low health literacy, socioeconomic disadvantages, and/or multipl...

What is the current status of trial NCT06937827?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-06-26. Estimated completion is 2027-04-15.

What conditions does trial NCT06937827 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT06937827?

The interventions under investigation include: HF Kit and Follow-ups (BEHAVIORAL).

Who is sponsoring clinical trial NCT06937827?

This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06937827 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06937827's enrollment target sits among peer trials

150 13th of 42 higher than 30 of 42 other Heart Failure With Preserved Ejection Fraction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure With Preserved Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06937827, the US trial registry maintained by the National Library of Medicine. NCT06937827 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.